Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like RBI advises PSBs to have fair system for branch auditor appointments May 7, 2017 Inter Pipeline to Build $600M Polypropylene Facility April 2, 2019 LM76 introduces “New Design” pillow blocks and flange blocks March 28, 2018